Reply: Intra-patient heterogeneity of BRAF mutation status: fact or fiction?
Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.
L
L
Heinzerling
Department of Dermatology, University Hospital Erlangen, 91054 Erlangen, Germany.
G
G
Schuler
Department of Pathology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
A
A
Hartmann
1] Department of Pathology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany [2] Experimental Tumor Pathology, Department of Pathology, University of Erlangen-Nürnberg, 91054 Erlangen, Germany.
R
R
Schneider-Stock
D005260:Female; D018740:Genetic Heterogeneity; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics*; D020125:Mutation, Missense; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics*
D048493:Proto-Oncogene Proteins B-raf